Is a complete IMCR research report available?

No complete published report is available for Immunocore Holdings plc (IMCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Immunocore Holdings plc (IMCR)

NASDAQ: IMCR · USD

$32.7

+0.75 (+2.4%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	430.8M
Net income (ttm)	-18.1M
EPS (ttm)	-$0.36
Shares out	51.5M
Volume	173,302
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 430.8M
Net income (ttm): -18.1M
EPS (ttm): -$0.36
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001671927
Company name	Immunocore Holdings plc
Country	United Kingdom
Country code	US
CUSIP number	45258D105
Earnings date	2026-11-09
Earnings time	bmo
Employees	524
Employees change	31
Employees growth	6.29%
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
Industry	Biotechnology
IPO date	2021-02-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US45258D1054
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$32.72
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	IMCR
Website	https://www.immunocore.com

Metric

Value

Amount currency

USD

CIK code

0001671927

Company name

Immunocore Holdings plc

Country

United Kingdom

Country code

CUSIP number

45258D105

Earnings date

2026-11-09

Earnings time

bmo

Employees

524

Employees change

Employees growth

6.29%

Enterprise value

$1.2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2008

Industry

Biotechnology

IPO date

2021-02-05

Is primary listing

Yes

Is SPAC

ISIN number

US45258D1054

Last 10-K release date

2026-02-25

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.7B

Market cap category

Small-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$32.72

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

IMCR

Website

https://www.immunocore.com

Metric	Value
Earnings yield	-1.09%
EV/EBITDA	1,594.28x
EV/Sales	2.8x
FCF / EV yield	-3.41%
FCF yield	-2.49%
Forward EV/Sales	2.51x
Forward P/S	3.44x
P/B ratio	3.92x
P/S ratio	3.83x
Price / tangible book value	3.93x
Price/EBITDA ratio	2,183.24x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-1.09%

EV/EBITDA

1,594.28x

EV/Sales

2.8x

FCF / EV yield

-3.41%

FCF yield

-2.49%

Forward EV/Sales

2.51x

Forward P/S

3.44x

P/B ratio

3.92x

P/S ratio

3.83x

Price / tangible book value

3.93x

Price/EBITDA ratio

2,183.24x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	-0.66%
EBITDA margin	0.18%
Gross margin	32.87%
Operating margin	-0.66%
Pretax margin	-0.63%
Profit margin	-4.2%
Profit per employee	$-34,492
Revenue per employee	$822,090
ROA	-0.16%
ROA (5Y)	-10.32%
ROCE	-0.32%
ROE	-4.47%
ROE (5Y)	-34.96%
ROIC	-0.21%
SBC / revenue	7.87%
Tax / revenue	3.56%

Metric

Value

EBIT margin

-0.66%

EBITDA margin

0.18%

Gross margin

32.87%

Operating margin

-0.66%

Pretax margin

-0.63%

Profit margin

-4.2%

Profit per employee

$-34,492

Revenue per employee

$822,090

ROA

-0.16%

ROA (5Y)

-10.32%

ROCE

-0.32%

ROE

-4.47%

ROE (5Y)

-34.96%

ROIC

-0.21%

SBC / revenue

7.87%

Tax / revenue

3.56%

Metric	Value
EPS growth quarters	2
EPS growth years	4
FCF growth (Q)	-40.74%
Gross profit growth	23.76%
Gross profit growth (Q)	46.49%
Gross profit growth 3Y	15.95%
Net income growth quarters	2
Net income growth years	2
OCF growth (Q)	-38.65%
Revenue growth	20.96%
Revenue growth (Q)	18.34%
Revenue growth (QoQ)	8.67%
Revenue growth 3Y	25.19%
Revenue growth 5Y	61.86%
Revenue growth quarters	19
Revenue growth years	4

Metric

Value

EPS growth quarters

EPS growth years

FCF growth (Q)

-40.74%

Gross profit growth

23.76%

Gross profit growth (Q)

46.49%

Gross profit growth 3Y

15.95%

Net income growth quarters

Net income growth years

OCF growth (Q)

-38.65%

Revenue growth

20.96%

Revenue growth (Q)

18.34%

Revenue growth (QoQ)

8.67%

Revenue growth 3Y

25.19%

Revenue growth 5Y

61.86%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-6.2M
Depreciation and amortization	$3.6M
EBIT	$-2.9M
EBITDA	$756,000
EPS	$-0.36
FCF per share	$-0.80
Financing cash flow	$23.3M
Free cash flow	$-41.2M
Free cash flow minus SBC	$-75M
Gross profit	$141.6M
Income taxes	$15.3M
Investing cash flow	$7.8M
Net cash flow	$-3M
Net income	$-18.1M
Operating cash flow minus SBC	$-68.8M
Operating income	$-2.9M
Revenue	$430.8M
Stock-based compensation	$33.9M

Metric

Value

Capital expenditures

$-6.2M

Depreciation and amortization

$3.6M

EBIT

$-2.9M

EBITDA

$756,000

EPS

$-0.36

FCF per share

$-0.80

Financing cash flow

$23.3M

Free cash flow

$-41.2M

Free cash flow minus SBC

$-75M

Gross profit

$141.6M

Income taxes

$15.3M

Investing cash flow

$7.8M

Net cash flow

$-3M

Net income

$-18.1M

Operating cash flow minus SBC

$-68.8M

Operating income

$-2.9M

Revenue

$430.8M

Stock-based compensation

$33.9M

Metric	Value
Altman Z-Score	1.65
Book value per share	$8.15
Debt / EBITDA	575.34
Debt / equity	1.04
Interest coverage	-0.23
Long-term assets	$68.4M
Long-term liabilities	$464.4M
Net cash (debt)	$445.3M
Net cash / market cap	26.98%
Net cash growth	-0.25%
Net debt / EBITDA	-588.96
Net debt / equity	-1.06
Piotroski F-Score	2
Property, plant and equipment	$49.9M
Shareholders' equity	$419.8M
Tangible book value	$419.8M
Tangible book value per share	$8.15
Total assets	$1.1B
Total cash	$880.2M
Total debt	$435M
Total liabilities	$699.6M
WACC	7.38%

Metric

Value

Altman Z-Score

1.65

Book value per share

$8.15

Debt / EBITDA

575.34

Debt / equity

1.04

Interest coverage

-0.23

Long-term assets

$68.4M

Long-term liabilities

$464.4M

Net cash (debt)

$445.3M

Net cash / market cap

26.98%

Net cash growth

-0.25%

Net debt / EBITDA

-588.96

Net debt / equity

-1.06

Piotroski F-Score

Property, plant and equipment

$49.9M

Shareholders' equity

$419.8M

Tangible book value

$419.8M

Tangible book value per share

$8.15

Total assets

$1.1B

Total cash

$880.2M

Total debt

$435M

Total liabilities

$699.6M

WACC

7.38%

Metric	Value
Asset turnover	0.39
Current assets	$1.1B
Current liabilities	$235.2M
Current ratio	4.47
Inventory turnover	43.66
Net working capital	$-62.5M
Quick ratio	4.15
Working capital	$815.8M
Working capital turnover	0.52

Metric

Value

Asset turnover

0.39

Current assets

$1.1B

Current liabilities

$235.2M

Current ratio

4.47

Inventory turnover

43.66

Net working capital

$-62.5M

Quick ratio

4.15

Working capital

$815.8M

Working capital turnover

0.52

Metric	Value
Buyback yield / dilution	-1.14%
Dividend yield	0%
Shareholder yield	-1.14%

Metric

Value

Buyback yield / dilution

-1.14%

Dividend yield

Shareholder yield

-1.14%

Metric	Value
150-day SMA	$31.56
1D price change	2.36%
1M price change	4.93%
1M total return	4.93%
1W price change	-1.12%
1W total return	-1.12%
1Y price change	-3.66%
1Y return CAGR	-3.66%
1Y total return	-3.66%
20-day SMA	$30.22
200-day SMA	$31.78
3M price change	-4.55%
3M total return	-4.55%
3Y price change	-24.77%
3Y return CAGR	-9.05%
3Y total return	-24.77%
50-day SMA	$32.59
50-day SMA vs 200-day SMA	50over200
52-week high	$40.72
52-week high date	2025-12-05
52-week low	$27.50
52-week low date	2026-10-14
5Y price change	-15.01%
5Y return CAGR	-3.2%
5Y total return	-15.01%
6M price change	12.87%
6M total return	12.87%
All-time high	$76.98
All-time high date	2024-02-01
All-time low	$18.43
All-time low date	2022-01-21
Average true range (ATR)	$1.34
Average volume	500.6K
Beta (1Y)	0.01
Beta (2Y)	0.58
Beta (5Y)	0.82
Change from 52-week high	-19.65%
Change from 52-week low	18.96%
Change from all-time high	-58.13%
Change from all-time low	74.91%
Change from open	2.49%
Day's gap	-0.13%
Dollar volume	$5.7M
High price	$32.72
Low price	$31.92
Monthly RSI	46.67
Open price	$31.92
Position in 52-week range	99.38%
Previous close	$31.96
Price vs 150-day SMA	2.14%
Price vs 20-day SMA	6.66%
Price vs 200-day SMA	1.43%
Price vs 50-day SMA	-1.08%
Relative volume	0.35
Return from IPO open	-21.83%
Return from IPO price	23.27%
RSI	57.25
Sharpe ratio	-0.03
Sharpe ratio (3Y)	-0.18
Sharpe ratio (5Y)	0.08
Sortino ratio	0.12
Sortino ratio (3Y)	-0.12
Sortino ratio (5Y)	0.23
Volume	173.3K
Weekly RSI	50.77
YTD price change	-7.13%
YTD total return	-7.13%

Metric

Value

150-day SMA

$31.56

1D price change

2.36%

1M price change

4.93%

1M total return

4.93%

1W price change

-1.12%

1W total return

-1.12%

1Y price change

-3.66%

1Y return CAGR

-3.66%

1Y total return

-3.66%

20-day SMA

$30.22

200-day SMA

$31.78

3M price change

-4.55%

3M total return

-4.55%

3Y price change

-24.77%

3Y return CAGR

-9.05%

3Y total return

-24.77%

50-day SMA

$32.59

50-day SMA vs 200-day SMA

50over200

52-week high

$40.72

52-week high date

2025-12-05

52-week low

$27.50

52-week low date

2026-10-14

5Y price change

-15.01%

5Y return CAGR

-3.2%

5Y total return

-15.01%

6M price change

12.87%

6M total return

12.87%

All-time high

$76.98

All-time high date

2024-02-01

All-time low

$18.43

All-time low date

2022-01-21

Average true range (ATR)

$1.34

Average volume

500.6K

Beta (1Y)

0.01

Beta (2Y)

0.58

Beta (5Y)

0.82

Change from 52-week high

-19.65%

Change from 52-week low

18.96%

Change from all-time high

-58.13%

Change from all-time low

74.91%

Change from open

2.49%

Day's gap

-0.13%

Dollar volume

$5.7M

High price

$32.72

Low price

$31.92

Monthly RSI

46.67

Open price

$31.92

Position in 52-week range

99.38%

Previous close

$31.96

Price vs 150-day SMA

2.14%

Price vs 20-day SMA

6.66%

Price vs 200-day SMA

1.43%

Price vs 50-day SMA

-1.08%

Relative volume

0.35

Return from IPO open

-21.83%

Return from IPO price

23.27%

RSI

57.25

Sharpe ratio

-0.03

Sharpe ratio (3Y)

-0.18

Sharpe ratio (5Y)

0.08

Sortino ratio

0.12

Sortino ratio (3Y)

-0.12

Sortino ratio (5Y)

0.23

Volume

173.3K

Weekly RSI

50.77

YTD price change

-7.13%

YTD total return

-7.13%

Metric	Value
Float	45.8M
Float percentage	89%
Shares change (QoQ)	-3.7%
Shares change (YoY)	1.14%
Shares held by insiders	0.1%
Shares held by institutions	87.02%
Shares outstanding	51.5M
Short % of shares	17.05%
Short ratio	20.7 days

Metric

Value

Float

45.8M

Float percentage

89%

Shares change (QoQ)

-3.7%

Shares change (YoY)

1.14%

Shares held by insiders

0.1%

Shares held by institutions

87.02%

Shares outstanding

51.5M

Short % of shares

17.05%

Short ratio

20.7 days

Immunocore Holdings plc (IMCR)

Price

Financial snapshot

Fair-value bridge

Latest news · IMCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IMCR

Frequently asked questions